“Efficacy and safety of secukinumab in the treatment of chronic plaque psoriasis: A 52-weeks follow up study”, J Pak Assoc Dermatol, vol. 34, no. 1, pp. 191–199, May 2024, doi: 10.66344/jpad.v34i1.2545.